Filing Flows

Filing Flows › Companies › HealthLynked › Cash flow

HealthLynked cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$350K in Q2 2026 · −$1.4M over twelve months

Operating cash flow−$350K
Free cash flow−$350K

Analysis

In Q2 2026, HealthLynked generated −$350K of operating cash flow. That is $67K more than in Q2 2025 (−$418K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$1.4M; the largest uses were operating cash flow ($1.4M); besides operations, cash came from net borrowing (+) / repaid (−) ($825K), other financing ($478K); the cash balance fell by $7K.

Operating cash flow was −$350K against net income of −$820K. The largest differences: payables +$128K, stock-based pay +$88K, depreciation & amortization +$10K.

Free cash flow

HealthLynked: free cash flow by quarterHealthLynked: free cash flow by quarter−$1.0MQ3 2024−$744KQ4 2024−$433KQ1 2025−$418KQ2 2025−$444KQ3 2025−$419KQ4 2025−$222KQ1 2026−$350KQ2 2026
Operating cash flow less capital spending.
HealthLynked: operating cash flow against capital spendingHealthLynked: operating cash flow against capital spendingOperating cash flowCapital spending−$1.0M$0Q3 2024−$744K$0Q4 2024−$433K$0Q1 2025−$418K$0Q2 2025−$444K$0Q3 2025−$419K$0Q4 2025−$222K$0Q1 2026−$350K$0Q2 2026
Latest (Q2 2026): Operating cash flow −$350K, Capital spending $0.

Capital allocation, year by year

HealthLynked: where the cash came from (up) and went (down), by fiscal yearHealthLynked: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksFY2021: Operating cash flow −$3.8MFY2021: Net borrowing −$51KFY2021: Shares issued $7.0MFY2021: Capital spending −$19KFY2021: Buybacks −$8K$7.0MFY2021FY2022: Operating cash flow −$4.4MFY2022: Net borrowing $489KFY2022: Shares issued $957KFY2022: Asset sales $2.2MFY2022: Capital spending −$24KFY2022: Acquisitions −$314K$3.7MFY2022FY2023: Operating cash flow −$4.1MFY2023: Net borrowing $187KFY2023: Shares issued $850KFY2023: Asset sales $500KFY2023: Capital spending −$2K$1.5MFY2023FY2024: Operating cash flow −$3.5MFY2024: Net borrowing $2.7MFY2024: Shares issued $405KFY2024: Capital spending −$3K$3.1MFY2024FY2025: Operating cash flow −$1.7MFY2025: Net borrowing $630KFY2025: Shares issued $30KFY2025: Asset sales $125K$785KFY2025
Over these 5 years operating cash flow totalled −$17.5M; the largest uses were operating cash flow ($17.5M) and acquisitions ($314K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$13K
Debtnone
Net cash$13K
Cash runway0 months

HealthLynked is burning cash: its operations consume cash, a free cash flow of −$1.4M a year at the current rate against $13K of cash and investments: a runway of about 0 months before any new financing.

Where the cash came from and went

HealthLynked: sources (+) and uses (−) of cash, Q2 2026HealthLynked: sources (+) and uses (−) of cash, Q2 2026Other financing$415KOperating cash flow−$350KNet borrowing (+) / repaid (−)−$76KCash drawn (+) / kept (−)$11K
HealthLynked: sources (+) and uses (−) of cash, TTM to Q2 2026HealthLynked: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$1.4MNet borrowing (+) / repaid (−)$825KOther financing$478KNot reconciled$125KCash drawn (+) / kept (−)$7K

From profit to cash

HealthLynked: net income to operating cash flow, Q2 2026HealthLynked: net income to operating cash flow, Q2 2026Net income−$820KDepreciation & amortization$10KStock-based pay$88KInventory$170Payables$128KDeferred revenue−$2KOperating cash flow−$350K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$350K−$76K—$11K−$350K
Q1 2026−$222K$149K—$13K−$222K
Q4 2025−$419K$37K$20K−$26K−$419K
Q3 2025−$444K$491K—$9K−$444K
Q2 2025−$418K$415K—$2K−$418K
Q1 2025−$433K$369K$10K$54K−$433K
Q4 2024−$744K−$115K—−$61K−$744K
Q3 2024−$1.0M−$116K—$158K−$1.0M

HealthLynked: income statement and cash flow

HealthLynked, Q2 2026: revenue $250K (-58% year over year), operating margin -215.7%. The chart follows the revenue to costs, profit and cash.

HealthLynked: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.